PPMD's Blog – January 2017 Archive (7)

PPMD Designates Yale New Haven Children's Hospital a Certified Duchenne Care Center

Yale New Haven Children's Hospital's Muscular Dystrophy Program became the 13th clinic named a Certified Duchenne…


Added by PPMD on January 19, 2017 at 11:30am — No Comments

PPMD Awards $600,000 Grant to NJIT & Talem for Next Phase of Upper Extremity Exoskeleton



Ensuring that the worlds of teens and adults with Duchenne 'grow bigger', as they grow older by expanding their reach – both literally and figuratively.


Combing your hair. Lifting a glass to your mouth. Washing your hands. Pressing elevator buttons. Zipping a coat. Opening a door. Turning on a light.…


Added by PPMD on January 18, 2017 at 9:00am — 1 Comment

ATTENTION: All Patients on Masters’ Deflazacort

As you know, the FDA is currently reviewing Marathon Pharmaceutical’s New Drug Application (NDA) for deflazacort for the treatment of Duchenne. It is our understanding that a decision is expected to be made…


Added by PPMD on January 16, 2017 at 6:30pm — No Comments

Akashi Therapeutics Provides Update on Three Duchenne Compounds

This weekend, Akashi Therapeutics announced they are working toward having three novel, complementary compounds in the clinic in 2017 with potential to treat all Duchenne patients independent of their specific genetic mutation.

This is promising news for a…


Added by PPMD on January 11, 2017 at 9:00am — No Comments

Sarepta Therapeutics Enters into Research Agreement and Option Agreement with Nationwide Children’s Hospital for Microdystrophin Gene Therapy Program

On the heels of PPMD’s announcement last week of a $2.2 million grant to Nationwide Children’s Hospital’s gene therapy study being led by Dr. Jerry Mendell and Dr. Louise Rodino-Klapac, Sarepta Therapeutics today announced their commitment to the trial through a separate research agreement with Nationwide Children’s, including an…


Added by PPMD on January 10, 2017 at 10:30am — No Comments

PTC Provides Update on Next Steps for Translarna

In a corporate update released today, PTC Therapeutics announced next steps for their drug, Translarna in the U.S. According to the release, PTC plans to file the Translarna New Drug Application (NDA) for nmDMD over protest with the U.S. FDA in…


Added by PPMD on January 9, 2017 at 10:30am — No Comments

Monthly Archives










Need help using this community site? Visit Ning's Help Page.



© 2022   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service